{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:58:57Z","timestamp":1790765937281,"version":"4.1.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,30]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Residual kidney function (RKF) is a major prognostic determinant in hemodialysis (HD), strongly influencing morbidity, mortality and quality of life. Although proteinuria is a well-established marker of chronic kidney disease progression, its prognostic relevance at the initiation of HD remains uncertain. This study aimed to assess the association between baseline proteinuria and RKF decline during the first year of HD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a prospective study of incident online hemodiafiltration (online-HDF) patients with preserved RKF, defined as kidney urea clearance (KrU) \u22652.5\u00a0mL\/min and urine output &amp;gt;500\u00a0mL\/day. The primary endpoint was RKF loss at 1\u00a0year, defined as KrU &amp;lt;2.5\u00a0mL\/min. Secondary endpoints included changes in creatinine clearance (KrCr), glomerular filtration rate and 24-h urine volume. Proteinuria was quantified using both 24-h urinary protein excretion and the urine protein-to-creatinine ratio.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ninety-seven patients were included; 74.2% were male, with a mean age of 64.3\u00a0\u00b1\u00a015\u00a0years. Among the 35 patients who reached the primary outcome, 62.9% had nephrotic-range proteinuria, compared with 25.5% with proteinuria &amp;lt;3.5\u00a0g\/24\u00a0h (P\u00a0=\u00a0.02). Of those whose urine output fell below 500\u00a0mL\/day at 1\u00a0year, 73% had baseline proteinuria \u22653.5\u00a0g\/24\u00a0h. The most frequent underlying nephropathies among patients with RKF loss were diabetic kidney disease (43%), vascular disease (17%) and glomerulonephritis (17%). Patients with proteinuria \u22653.5\u00a0g\/24\u00a0h reached RKF loss significantly earlier (log-rank\u00a0=\u00a05.25; P\u00a0=\u00a0.02). Nephrotic-range proteinuria was associated with a higher risk of RKF decline (hazard ratio 2.04; 95% confidence interval 1.03\u20134.02; P\u00a0=\u00a0.04), a finding that remained consistent across adjusted models. \u03b22-microglobulin levels were also significantly higher in this group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Nephrotic-range proteinuria at online-HDF initiation is an independent predictor of accelerated RKF loss, including progression to anuria. Its association with elevated \u03b22-microglobulin supports its value as a prognostic marker. Early identification of high-proteinuria patients may enable personalized strategies to preserve RKF and improve outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ndt\/gfag058","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:48:26Z","timestamp":1773330506000},"page":"1868-1877","source":"Crossref","is-referenced-by-count":0,"title":["The deleterious effect of proteinuria in residual kidney function in hemodialysis patients"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7835-543X","authenticated-orcid":false,"given":"Beatriz S\u00e1nchez","family":"Alamo","sequence":"first","affiliation":[{"name":"Hospital Universitario Ram\u00f3n y Cajal, IRYCIS Department of Nephrology, , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Minguez","sequence":"additional","affiliation":[{"name":"Hospital Universitario Ram\u00f3n y Cajal, IRYCIS Department of Nephrology, , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha Elisabeth D\u00edaz","family":"Dom\u00ednguez","sequence":"additional","affiliation":[{"name":"Hospital Universitario Ram\u00f3n y Cajal, IRYCIS Department of Nephrology, , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria Rodr\u00edguez","family":"Mendiola","sequence":"additional","affiliation":[{"name":"Hospital Universitario Ram\u00f3n y Cajal, IRYCIS Department of Nephrology, , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milagros\u00a0Fern\u00e1ndez","family":"Lucas","sequence":"additional","affiliation":[{"name":"Hospital Universitario Ram\u00f3n y Cajal, IRYCIS Department of Nephrology, , Madrid ,","place":["Spain"]},{"name":"Universidad de Alcal\u00e1, Alcal\u00e1 de Henares , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"2026093006070267800_bib1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.kint.2016.02.037","article-title":"Preservation of residual kidney function in hemodialysis patients: reviving an old concept","volume":"90","author":"Mathew","year":"2016","journal-title":"Kidney Int"},{"key":"2026093006070267800_bib2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s11255-010-9767-y","article-title":"The relationship between chronic volume overload and elevated blood pressure in hemodialysis patients: use of bioimpedance provides a different perspective from echocardiography and biomarker methodologies","volume":"42","author":"Voroneanu","year":"2010","journal-title":"Int Urol Nephrol"},{"key":"2026093006070267800_bib3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1081\/JDI-120039825","article-title":"Should the preservation of residual renal function cost volume overload and its consequence left ventricular hypertrophy in new hemodialysis patients?","volume":"26","author":"Gunal","year":"2004","journal-title":"Ren Fail"},{"key":"2026093006070267800_bib4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1159\/000104870","article-title":"Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration","volume":"25","author":"Fry","year":"2007","journal-title":"Blood Purif"},{"key":"2026093006070267800_bib5","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.ekir.2017.06.005","article-title":"Feasibility of incremental 2-times weekly hemodialysis in incident patients with residual kidney function","volume":"2","author":"Chin","year":"2017","journal-title":"Kidney Int Rep"},{"key":"2026093006070267800_bib6","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1681\/ASN.2015101142","article-title":"Residual kidney function decline and mortality in incident hemodialysis patients","volume":"27","author":"Obi","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2026093006070267800_bib7","first-page":"ii5","article-title":"EBPG guideline on dialysis strategies","volume":"22 Suppl 2","author":"Tattersall","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"2026093006070267800_bib8","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1053\/j.ajkd.2006.03.051","article-title":"Clinical practice guidelines for hemodialysis adequacy, update 2006","volume":"48 Suppl 1","author":"Hemodialysis Adequacy 2006 Work Group","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"2026093006070267800_bib9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/039139888901200305","article-title":"Loss of residual renal function in patients on regular haemodialysis","volume":"12","author":"Iest","year":"1989","journal-title":"Int J Artif Organs"},{"key":"2026093006070267800_bib10","doi-asserted-by":"publisher","first-page":"e1561","DOI":"10.1111\/jocn.14309","article-title":"Measuring the prevalence of intradialytic hypotension in a satellite dialysis clinic: are we too complacent?","volume":"27","author":"Steinwandel","year":"2018","journal-title":"J Clin Nurs"},{"key":"2026093006070267800_bib11","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1093\/ndt\/17.10.1814","article-title":"Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients","volume":"17","author":"Schiffl","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"2026093006070267800_bib12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1159\/000365819","article-title":"Association of initial twice-weekly hemodialysis treatment with preservation of residual kidney function in ESRD patients","volume":"40","author":"Zhang","year":"2014","journal-title":"Am J Nephrol"},{"key":"2026093006070267800_bib13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/236245","article-title":"Incremental hemodialysis schedule in patients with higher residual renal function at the start of dialysis","volume":"2014","author":"Lucas","year":"2014","journal-title":"Adv Nephrol"},{"key":"2026093006070267800_bib14","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1016\/j.ekir.2025.09.048","article-title":"Randomized trial of twice-weekly versus thrice-weekly hemodiafiltration for initiation of renal replacement therapy","volume":"10","author":"Lucas","year":"2025","journal-title":"Kidney Int Rep"},{"key":"2026093006070267800_bib15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5402\/2013\/184527","article-title":"Residual renal function in hemodialysis patients: the role of angiotensin-converting enzyme inhibitor in its preservation","volume":"2013","author":"Xydakis","year":"2013","journal-title":"ISRN Nephrol"},{"key":"2026093006070267800_bib16","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.3390\/biomedicines11071908","article-title":"Efficacy and safety of the use of SGLT2 inhibitors in patients on incremental hemodialysis: maximizing residual renal function, is there a role for SGLT2 inhibitors?","volume":"11","author":"De","year":"2023","journal-title":"Biomedicines"},{"key":"2026093006070267800_bib17","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3390\/medicina60081198","article-title":"Effects of sodium-glucose cotransporter 2 inhibitors in diabetic and non-diabetic patients with advanced chronic kidney disease in peritoneal dialysis on residual kidney function: in real-world data","volume":"60","author":"Moral\u00a0Berrio","year":"2024","journal-title":"Medicina (Kaunas)"},{"key":"2026093006070267800_bib18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000527919","article-title":"Efficacy and safety of semaglutide, a glucagon-like peptide-1 receptor agonist in real-life: a case series of patients in maintenance incremental hemodialysis","volume":"12","author":"De\u00a0la\u00a0Flor","year":"2022","journal-title":"Case Rep Nephrol Dial"},{"key":"2026093006070267800_bib19","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1046\/j.1523-1755.2002.00505.x","article-title":"Predictors of the rate of decline of residual renal function in incident dialysis patients","volume":"62","author":"Jansen","year":"2002","journal-title":"Kidney Int"},{"key":"2026093006070267800_bib20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/sdi.12701","article-title":"Incremental dialysis for preserving residual kidney function-does one size fit all when initiating dialysis?","volume":"31","author":"Mathew","year":"2018","journal-title":"Semin Dial"},{"key":"2026093006070267800_bib21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1053\/ajkd.2001.25198","article-title":"Residual renal function and mortality risk in hemodialysis patients","volume":"38","author":"Shemin","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"2026093006070267800_bib22","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1093\/ndt\/gfq856","article-title":"Full loss of residual renal function causes higher mortality in dialysis patients; findings from a marginal structural model","volume":"26","author":"van\u00a0der\u00a0Wal","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"2026093006070267800_bib23","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"2026093006070267800_bib24","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner\u00a0Barry","year":"2001","journal-title":"N Engl J Med"},{"key":"2026093006070267800_bib25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0140-6736(98)10363-X","article-title":"Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria","volume":"354","author":"Ruggenenti","year":"1999","journal-title":"Lancet"},{"key":"2026093006070267800_bib26","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1681\/ASN.V113556","article-title":"Predictors of loss of residual renal function among new dialysis patients","volume":"11","author":"Moist","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"2026093006070267800_bib27","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1053\/j.ajkd.2014.05.011","article-title":"Angiotensin blockade and progressive loss of kidney function in hemodialysis patients: a randomized controlled trial","volume":"64","author":"Kjaergaard","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"2026093006070267800_bib28","doi-asserted-by":"publisher","first-page":"18103","DOI":"10.1038\/s41598-019-54572-6","article-title":"Renin angiotensin aldosterone system blockades does not protect residual renal function in patients with hemodialysis at 1 year after dialysis initiation: a prospective observational cohort study","volume":"9","author":"Yoo","year":"2019","journal-title":"Sci Rep"},{"key":"2026093006070267800_bib29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fmed.2017.00073","article-title":"Rediscovering beta-2 microglobulin as a biomarker across the spectrum of kidney diseases","volume":"4","author":"Argyropoulos","year":"2017","journal-title":"Front Med"},{"key":"2026093006070267800_bib30","first-page":"151","article-title":"Evaluation of plasma beta-2-microglobulin in patients with the nephrotic syndrome","volume":"12","author":"Adeyemi","year":"2001","journal-title":"Saudi J Kidney Dis Transplant"},{"key":"2026093006070267800_bib31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00296-022-05221-1","article-title":"Serum beta-2 microglobulin as a predictor of nephritis, disease activity, and damage score in systemic lupus erythematosus: a cross-sectional study","volume":"43","author":"Gamal","year":"2023","journal-title":"Rheumatol Int"},{"key":"2026093006070267800_bib32","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.kint.2015.12.042","article-title":"Predicting residual kidney function in hemodialysis patients using serum \u03b2-trace protein and \u03b22-microglobulin","volume":"89","author":"Wong","year":"2016","journal-title":"Kidney Int"},{"key":"2026093006070267800_bib33","first-page":"640","article-title":"Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis","volume":"33","author":"Teruel-Briones","year":"2013","journal-title":"Nefrologia"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfag058\/67338714\/gfag058.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/10\/1868\/67338714\/gfag058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/10\/1868\/67338714\/gfag058.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:07:10Z","timestamp":1790762830000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/41\/10\/1868\/8519151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":33,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,3,13]]},"published-print":{"date-parts":[[2026,9,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfag058","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,3,13]]}}}